EHA l European Hematology Association’s Annual Congress
EHA 2024
New Data from EHA Shared and Discussed at Danish Evening
- / Jan Andreasen
Gå ikke glipp av de siste nyhetene fra ditt spesialområde
Registrer deg og få nye artikler, MEDtalks og digitale tidsskrifter direkte til din innboks
Abstract EHA 2024
Myelomatose
Choice of Selinexor in the Treatment of Myeloma
/ Fredrik Schjesvold
Mer fra EHA 2024
Promising Avenues for the Development of Personalized Treatment for FVII Deficiency
/ Maria Eugenia Chollet
An Excellent Target with a Wide Therapeutic Window in del(5q) Myeloid Malignancies
/ Sergio Martinez Høyer
Management of ALL in Adults: 2024 ELN Recommendations
/ Henrik Hjorth-Hansen
Development of Prediction Models for Survival among Hodgkin Lymphoma Patients
/ Rasmus Rask Kragh Jørgensen
Better Predictor of Treatment Efficacy of Myelodysplastic Syndromes
/ Ângela Sofia Gerós Mesquita
The Missing Link of Light Chain Smoldering Multiple Myeloma
/ Sigrun Thorsteinsdottir
Høydepunkter fra EHA 2023
EHA 2022
Superior safety profile for decitabine vs chemotherapy for older patient with AML
/ BestPractice Nordic
Behandling af CLL patienter, der også har type 2 diabetes
/ Emelie Hamotal Curovic Rotbain